Results
|
13021.
|
|
|
13022.
|
|
|
13023.
|
|
|
13024.
|
|
|
13025.
|
|
|
13026.
|
|
|
13027.
|
|
|
13028.
|
|
|
13029.
|
|
|
13030.
|
|
|
13031.
|
|
|
13032.
|
|
|
13033.
|
|
|
13034.
|
|
|
13035.
|
Pharmacokinetics of cisplatin administered by continuous hyperthermic peritoneal perfusion (CHPP) to patients with peritoneal carcinomatosis. [electronic resource] by
- Cho, H K
- Lush, R M
- Bartlett, D L
- Alexander, H R
- Wu, P C
- Libutti, S K
- Lee, K B
- Venzon, D J
- Bauer, K S
- Reed, E
- Figg, W D
Producer: 19990623
In:
Journal of clinical pharmacology vol. 39
Availability: No items available.
|
|
13036.
|
Structure-based design, synthesis, and biological evaluation of irreversible human rhinovirus 3C protease inhibitors. 3. Structure-activity studies of ketomethylene-containing peptidomimetics. [electronic resource] by
- Dragovich, P S
- Prins, T J
- Zhou, R
- Fuhrman, S A
- Patick, A K
- Matthews, D A
- Ford, C E
- Meador, J W
- Ferre, R A
- Worland, S T
Producer: 19990520
In:
Journal of medicinal chemistry vol. 42
Availability: No items available.
|
|
13037.
|
Structure-based design, synthesis, and biological evaluation of irreversible human rhinovirus 3C protease inhibitors. 4. Incorporation of P1 lactam moieties as L-glutamine replacements. [electronic resource] by
- Dragovich, P S
- Prins, T J
- Zhou, R
- Webber, S E
- Marakovits, J T
- Fuhrman, S A
- Patick, A K
- Matthews, D A
- Lee, C A
- Ford, C E
- Burke, B J
- Rejto, P A
- Hendrickson, T F
- Tuntland, T
- Brown, E L
- Meador, J W
- Ferre, R A
- Harr, J E
- Kosa, M B
- Worland, S T
Producer: 19990520
In:
Journal of medicinal chemistry vol. 42
Availability: No items available.
|
|
13038.
|
|
|
13039.
|
|
|
13040.
|
|